Overview

At a Glance

  • PCT: growing business providing development, manufacturing and delivery of cell-based therapies - Averaging 25% year-over-year revenue growth over past two years - Unmatched cell and cell-based gene therapy-specific experience and expertise - Expansive list of noteworthy cell and cell-based gene therapy clients
  • Focused pipeline of highly promising cell therapies - Leverages internal specialized cell therapy clinical development expertise and PCT’s CMC prowess - Partnering post-POC provides value inflection and an additional stream of new PCT clients - CLBS03 – Treg cell therapy targeting adolescents with recent-onset type 1 diabetes
  • Highly experienced management and domain-specific scientific team

Webcasts

Caladrius’ management will host a conference call for the investment community beginning at 5:00 pm ET on Thursday, May 5, 2016, to discuss the financial results and to answer questions. Shareholders and other interested parties may participate in the conference call by dialing (877) 562-4460 (US) or (513) 438-4106 (International) and entering passcode 95709217.

Caladrius’ management hosted a conference call for the investment community on 5:00 on Tuesday, March 15, 2016. An archived version of the call can accessed at https://engage.vevent.com/rt/caladriusao~030216.

Company management hosted a conference call to discuss their recent announcement of strategic refocus on January 7, 2016, at 8:30 am Eastern time.
To access an archive of the call visit https://engage.vevent.com/rt/caladriusao~010516. The archived call will be available for 90 days.


Stock Chart

Maximum 30 minute delay for quote.

Sign up to our e-mail list to receive Caladrius announcements.


  • Caladrius Biosciences to Host 2016 First Quarter Financial Results Conference Call on May 5 at 5:00 pm Eastern Time

    Caladrius’ management will host a conference call for the investment community beginning at 5:00 pm ET on Thursday, May 5, 2016, to discuss the financial results and to answer questions.

    Shareholders and other interested parties may participate in the conference call by dialing (877) 562-4460 (US) or (513) 438-4106 (International) and entering passcode 95709217. The call will also be broadcast live on the Internet via the Company’s website.

    The call will be archived on the Company’s website for 90 days.

  • Bio Korea 2016

    BIO Korea 2016

    Venue: COEX, Seoul, South Korea

    Session 1

    • Date and Time: Thursday, March 31, 2016, 9:20 AM KST
    • Speaker: Dr. Robert Preti, Senior Vice President, Manufacturing and Technical Operations and Chief Technology Officer, Caladrius; President of PCT
    • Topic: Recent Trends in Technology Development and Products Commercialization

    Session 2

    • Date and Time: Thursday, March 31, 2016, 10:50 AM KST
    • Speaker: Dr. Robert Preti, Senior Vice President, Manufacturing and Technical Operations and Chief Technology Officer, Caladrius; President of PCT
    • Topic: Future Perspectives of Stem Cells and Regenerative Medicine Industry
  • JCS 2016

    80th Annual Scientific Meeting of the Japanese Circulation Society (JCS)

    • Venue: Sendai International Center, Sendai, Japan
    • Presenter: Dr. Atsuhiko Kawamoto
    • Topic: An Update on Therapeutic Strategies for Japanese Patients with Critical Limb Ischemia
  • JSRM

    14th Congress of the Japanese Society for Regenerative Medicine (JSRM)

    • Venue: Osaka International Convention Center, Osaka, Japan
    • Presenter: Dr. Atsuhiko Kawamoto
    • Topic: G-CSF mobilized CD34+ cell therapy for chronic lower limb ischemia
  • Caladrius Biosciences Logo

    2015 Fourth Quarter and Full Year Financial Results Conference Call

    Caladrius’ management hosted a conference call for the investment community on 5:00 on Tuesday, March 15, 2016. An archived version of the call can accessed at https://engage.vevent.com/rt/caladriusao~030216.


Investor Relations Contact


Lippert/Heilshorn & Associates
Anne Marie Fields
Phone: +1-212-838-3777
E-mail: afields@lhai.com

Media Contact


Caladrius Biosciences, Inc.
Eric Powers
Director of Communications and Marketing
Phone: +1-212-584-4173
Email: epowers@caladrius.com